These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 8898373

  • 41. Effect of dibutyryl cyclic adenosine monophosphate on the gene expression of plasminogen activator inhibitor-1 and tissue factor in adipocytes.
    Taniguchi M, Ono N, Hayashi A, Yakura Y, Takeya H.
    Thromb Res; 2011 Oct; 128(4):375-80. PubMed ID: 21496886
    [Abstract] [Full Text] [Related]

  • 42. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
    Skurk T, Hauner H.
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668
    [Abstract] [Full Text] [Related]

  • 43. Plasminogen activator and plasminogen activator inhibitor gene expression in human saphenous vein organ culture.
    Javed Q, Swanson N, Warner EL, Gershlick AH, de Bono DP.
    Exp Mol Pathol; 2001 Apr; 70(2):146-53. PubMed ID: 11263957
    [Abstract] [Full Text] [Related]

  • 44. Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity.
    Zaman AK, Fujii S, Goto D, Furumoto T, Mishima T, Nakai Y, Dong J, Imagawa S, Sobel BE, Kitabatake A.
    J Mol Cell Cardiol; 2004 Aug; 37(2):525-35. PubMed ID: 15276022
    [Abstract] [Full Text] [Related]

  • 45. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
    Rega G, Kaun C, Weiss TW, Demyanets S, Zorn G, Kastl SP, Steiner S, Seidinger D, Kopp CW, Frey M, Roehle R, Maurer G, Huber K, Wojta J.
    Circulation; 2005 Apr 19; 111(15):1938-45. PubMed ID: 15837947
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice.
    Allen DL, Cleary AS, Speaker KJ, Lindsay SF, Uyenishi J, Reed JM, Madden MC, Mehan RS.
    Am J Physiol Endocrinol Metab; 2008 May 19; 294(5):E918-27. PubMed ID: 18334608
    [Abstract] [Full Text] [Related]

  • 50. Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjects.
    Bastard JP, Vidal H, Jardel C, Bruckert E, Robin D, Vallier P, Blondy P, Turpin G, Forest C, Hainque B.
    Int J Obes Relat Metab Disord; 2000 Jan 19; 24(1):70-4. PubMed ID: 10702753
    [Abstract] [Full Text] [Related]

  • 51. Deficiency of plasminogen activator inhibitor-2 impairs nutritionally induced murine adipose tissue development.
    Lijnen HR, Frederix L, Scroyen I.
    J Thromb Haemost; 2007 Nov 19; 5(11):2259-65. PubMed ID: 17958744
    [Abstract] [Full Text] [Related]

  • 52. No functional role of plasminogen activator inhibitor-1 in murine adipogenesis or adipocyte differentiation.
    Scroyen I, Christiaens V, Lijnen HR.
    J Thromb Haemost; 2007 Jan 19; 5(1):139-45. PubMed ID: 17067365
    [Abstract] [Full Text] [Related]

  • 53. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
    He G, Andersen O, Haugaard SB, Lihn AS, Pedersen SB, Madsbad S, Richelsen B.
    Eur J Clin Invest; 2005 Sep 19; 35(9):583-90. PubMed ID: 16128865
    [Abstract] [Full Text] [Related]

  • 54. Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals.
    Yamamoto K, Takeshita K, Shimokawa T, Yi H, Isobe K, Loskutoff DJ, Saito H.
    Proc Natl Acad Sci U S A; 2002 Jan 22; 99(2):890-5. PubMed ID: 11792849
    [Abstract] [Full Text] [Related]

  • 55. The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels.
    Barnard SA, Pieters M, De Lange Z.
    Blood Rev; 2016 Nov 22; 30(6):421-429. PubMed ID: 27233154
    [Abstract] [Full Text] [Related]

  • 56. Impairment of adipose tissue development by hypoxia is not mediated by plasminogen activator inhibitor-1.
    Semeraro F, Voros G, Collen D, Lijnen HR.
    Thromb Haemost; 2006 Jan 22; 95(1):174-81. PubMed ID: 16543977
    [Abstract] [Full Text] [Related]

  • 57. A DNA enzyme against plasminogen activator inhibitor- type 1 (PAI-1) limits neointima formation after angioplasty in an obese diabetic rodent model.
    Witkowski P, Seki T, Xiang G, Martens T, Sondermeijer H, See F, Bhagat G, Schuster M, Hardy MA, Itescu S.
    J Cardiovasc Pharmacol; 2007 Dec 22; 50(6):633-40. PubMed ID: 18091579
    [Abstract] [Full Text] [Related]

  • 58. The role of the platelet pool of Plasminogen Activator Inhibitor-1 in well-controlled type 2 diabetes patients.
    Mossberg K, Olausson J, Fryk E, Jern S, Jansson PA, Brogren H.
    PLoS One; 2022 Dec 22; 17(8):e0267833. PubMed ID: 36044519
    [Abstract] [Full Text] [Related]

  • 59. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO.
    Invest Ophthalmol Vis Sci; 2002 Aug 22; 43(8):2799-805. PubMed ID: 12147618
    [Abstract] [Full Text] [Related]

  • 60. Obese gene expression: reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouti) obesity.
    Mizuno TM, Bergen H, Funabashi T, Kleopoulos SP, Zhong YG, Bauman WA, Mobbs CV.
    Proc Natl Acad Sci U S A; 1996 Apr 16; 93(8):3434-8. PubMed ID: 8622953
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.